Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Causse

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Acute thrombosis of the portal system. Treatment with alteplase and heparin or with heparin alone in 10 patients]J P Lagasse, M L Bahallah, N Salem, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 2, 2015
The high burden of hospitalizations for primary EBV infection: a 6-year prospective survey in a French hospitalL Hocqueloux, X Causse, A Valery, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2008
Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)M Doffoël, F Bonnetain, O Bouché, et al.
Journal of Viral Hepatitis|December 17, 2013
Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countriesH Leblebicioglu, V Arama, X Causse, et al.
Alimentary Pharmacology & Therapeutics|March 19, 2008
A national survey of acute hepatitis E in FranceC Renou, X Moreau, A Pariente, et al.
Hepatology (Baltimore, Md.)|March 21, 1998
Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferonJ P Zarski, M Maynard-Muet, S Chousterman, et al.
Gut|September 18, 2002
Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levelsC Renou, P Halfon, S Pol, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2007
Epidemiology of chronic hepatitis B infection in France: risk factors for significant fibrosis--results of a nationwide surveyJ-F Cadranel, P Lahmek, X Causse, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Acute thrombosis of the portal system. Treatment with alteplase and heparin or with heparin alone in 10 patients]J P Lagasse, M L Bahallah, N Salem, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 2, 2015
The high burden of hospitalizations for primary EBV infection: a 6-year prospective survey in a French hospitalL Hocqueloux, X Causse, A Valery, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2008
Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)M Doffoël, F Bonnetain, O Bouché, et al.
Journal of Viral Hepatitis|December 17, 2013
Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countriesH Leblebicioglu, V Arama, X Causse, et al.
Alimentary Pharmacology & Therapeutics|March 19, 2008
A national survey of acute hepatitis E in FranceC Renou, X Moreau, A Pariente, et al.
Hepatology (Baltimore, Md.)|March 21, 1998
Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferonJ P Zarski, M Maynard-Muet, S Chousterman, et al.
Gut|September 18, 2002
Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levelsC Renou, P Halfon, S Pol, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2007
Epidemiology of chronic hepatitis B infection in France: risk factors for significant fibrosis--results of a nationwide surveyJ-F Cadranel, P Lahmek, X Causse, et al.
Pageof 6